Alvotech and Dr Reddy’s Laboratories partner to develop biosimilar for Keytruda targeting global… EP News Bureau Jun 5, 2025 Collaboration aims to accelerate development and commercialisation of pembrolizumab biosimilar, expanding access to cancer…
Lupin announces presentation of phase 1 data on LNP7457 (PRMT5 inhibitor) at the ASCO – Annual… EP News Bureau May 27, 2025 Current data from Lupin indicates that LNP7457 is unique within its field and appears to be safe and well-tolerated as a…
